{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:33:03Z","timestamp":1790019183554,"version":"4.0.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jaip.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T21:38:22Z","timestamp":1684705102000},"page":"1989-1996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Disease Spectrum of Anaphylaxis Disorders"],"prefix":"10.1016","volume":"11","author":[{"given":"David","family":"Gonz\u00e1lez de Olano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley V.","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.05.012_bib1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.chest.2017.07.033","volume":"153","author":"LoVerde","year":"2018","journal-title":"Anaphylaxis. Chest"},{"key":"10.1016\/j.jaip.2023.05.012_bib2","series-title":"Middleton\u2019s Allergy","first-page":"1228","article-title":"Anaphylaxis","author":"Dreskin","year":"2020"},{"key":"10.1016\/j.jaip.2023.05.012_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2017.06.003","article-title":"The pathophysiology of anaphylaxis","volume":"140","author":"Reber","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2500\/aap.2019.40.4270","volume":"40","author":"Watts","year":"2019","journal-title":"Anaphylaxis. Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2023.05.012_bib5","series-title":"Cellular and Molecular Immunology","article-title":"Allergy","year":"2022"},{"key":"10.1016\/j.jaip.2023.05.012_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2023.05.012_bib7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jaci.2021.02.012","article-title":"Non-IgE-mediated anaphylaxis","volume":"147","author":"Cianferoni","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib8","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.3390\/ijms222011270","article-title":"Mastocytosis and mast cell activation disorders: clearing the air","volume":"22","author":"Jackson","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2023.05.012_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.iac.2021.09.007","article-title":"Anaphylaxis and mast cell disorders","volume":"42","author":"Gulen","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2023.05.012_bib10","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.2019000932","article-title":"New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis","volume":"135","author":"Reiter","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.05.012_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-16-2234","article-title":"Advances in the classification and treatment of mastocytosis: current status and outlook toward the future","volume":"77","author":"Valent","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaip.2023.05.012_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.012_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience","volume":"44","author":"Gulen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.012_bib14","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/blood-2013-01-453183","article-title":"How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage)","volume":"121","author":"Pardanani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.05.012_bib15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase\u2014a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jaip.2017.03.019","article-title":"Fatal anaphylaxis to yellow jacket stings in mastocytosis: options for identification and treatment of at-risk patients","volume":"5","author":"Vos","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.012_bib17","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.3390\/ijms21239030","article-title":"Diagnosis, classification and management of mast cell activation syndromes (MCAS) in the era of personalized medicine","volume":"21","author":"Valent","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2023.05.012_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11882-021-00988-y","article-title":"Idiopathic anaphylaxis: a perplexing diagnostic challenge for allergists","volume":"21","author":"Gulen","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2023.05.012_bib19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S1081-1206(10)62547-1","article-title":"Lymphocyte subsets and activation markers in patients with acute episodes of idiopathic anaphylaxis","volume":"85","author":"Grammer","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib20","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V96.4.1267","article-title":"Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology","volume":"96","author":"Akin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.05.012_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2017.06.007","article-title":"Mast cell activation syndromes","volume":"140","author":"Akin","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0091-6749(84)90309-9","article-title":"Exercise-induced anaphylaxis","volume":"73","author":"Sheffer","year":"1984","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaip.2018.06.018","article-title":"Wheat-dependent cofactor-augmented anaphylaxis: a prospective study of exercise, aspirin, and alcohol efficacy as cofactors","volume":"7","author":"Christensen","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.012_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/nu9010084","article-title":"Endurance exercise increases intestinal uptake of the peanut allergen Ara h 6 after peanut consumption in humans","volume":"9","author":"JanssenDuijghuijsen","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jaip.2023.05.012_bib25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jaip.2022.11.041","article-title":"Eating increases and exercise decreases disease activity in patients with symptomatic dermographism","volume":"11","author":"Ertas","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.012_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106557","article-title":"Gut microbiome alterations in patients with wheat-dependent exercise-induced anaphylaxis","volume":"84","author":"Du","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaip.2023.05.012_bib27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonzalez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.012_bib28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2003.11.033","article-title":"Vaccine Safety Datalink Team. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization","volume":"113","author":"Bohlke","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1440-1754.2000.00444.x","article-title":"Parent reported allergy and anaphylaxis in 4173 South Australian children","volume":"36","author":"Boros","year":"2000","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.jaip.2023.05.012_bib30","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2008.09.043","article-title":"The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project","volume":"122","author":"Decker","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib31","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jaci.2010.02.009","article-title":"Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review","volume":"125","author":"Gonzalez-Perez","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1258\/jrsm.2008.070306","article-title":"Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England","volume":"101","author":"Sheikh","year":"2008","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.jaip.2023.05.012_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1067\/mai.2002.127860","article-title":"Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis","volume":"110","author":"Simons","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib34","first-page":"578","article-title":"Incidence of anaphylaxis in the city of Alcorcon (Spain): a population-based study","volume":"42","author":"Tejedor Alonso","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.012_bib35","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.05.012_bib36","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2023.05.012_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib38","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib39","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/cea.12369","article-title":"The presence of mast cell clonality in patients with unexplained anaphylaxis","volume":"44","author":"Gulen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.012_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A\u00a0distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib41","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jaip.2022.11.042","article-title":"Mast cell activation syndromes: comparison between two scoring models to predict for mast cell clonality","volume":"11","author":"Rama","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.012_bib42","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jaip.2022.03.007","article-title":"Personalized management strategies in mast cell disorders: ECNM-AIM user\u2019s guide for daily clinical practice","volume":"10","author":"Valent","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.012_bib43","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/modpathol.2015.72","article-title":"Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications","volume":"28","author":"Jara-Acevedo","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaip.2023.05.012_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.2012.01789.x","article-title":"Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis","volume":"89","author":"Kristensen","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaip.2023.05.012_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.23672","article-title":"Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis","volume":"89","author":"Kristensen","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2023.05.012_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay","volume":"13","author":"Kristensen","year":"2011","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jaip.2023.05.012_bib47","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood.2018886507","article-title":"Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis","volume":"134","author":"Munoz-Gonzalez","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.05.012_bib48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/bjh.15624","article-title":"Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease","volume":"183","author":"Carter","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2023.05.012_bib49","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3504","article-title":"New approach to paediatric mastocytosis: implications of KIT D816V mutation detection in peripheral blood","volume":"100","author":"Czarny","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2023.05.012_bib50","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/all.13187","article-title":"Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis","volume":"72","author":"Kristensen","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.012_bib51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2017.277897","article-title":"Digital PCR: a sensitive and precise method for KIT D816V quantification in mastocytosis","volume":"64","author":"Greiner","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaip.2023.05.012_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12174","article-title":"Detection of clonal mast cell disease in wasp venom allergic patients with normal tryptase","volume":"12","author":"Onnes","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2023.05.012_bib53","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/all.15584","article-title":"KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes","volume":"78","author":"Navarro-Navarro","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.012_bib54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.anai.2019.11.023","article-title":"Mast cell activation syndromes and anaphylaxis: multiple diseases part of the same spectrum","volume":"124","author":"Gonzalez-de-Olano","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib55","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jaip.2023.05.012_bib56","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2500\/aap.2021.42.210012","article-title":"Mast cell activation syndrome: myths and realities","volume":"42","author":"Zhang","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2023.05.012_bib57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.012_bib58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000501079","article-title":"Why the 20%\u00a0+ 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome","volume":"180","author":"Valent","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib60","article-title":"Increased excretion of mast cell mediator metabolites during mast cell activation syndrome","author":"Butterfield","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract. Published online February 28"},{"key":"10.1016\/j.jaip.2023.05.012_bib61","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0002-9343(89)80398-5","article-title":"Analysis of plasma histamine levels in patients with mast cell disorders","volume":"87","author":"Friedman","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2023.05.012_bib62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib63","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaip.2019.12.015","article-title":"Epinephrine in the management of anaphylaxis","volume":"8","author":"Brown","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.012_bib64","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaip.2019.02.002","article-title":"Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management","volume":"7","author":"Castells","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.012_bib65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.anai.2021.06.017","article-title":"Use of omalizumab for management of idiopathic anaphylaxis: a systematic review and retrospective case series","volume":"127","author":"Kaminsky","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib66","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/cea.13592","article-title":"Omalizumab in the treatment of adult patients with mastocytosis: a systematic review","volume":"50","author":"Jendoubi","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.012_bib67","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","article-title":"IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria","volume":"142","author":"Schmetzer","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib68","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2021.06.030","article-title":"Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: a Work Group Report of the AAAAI Allergic Skin Diseases Committee","volume":"148","author":"Zimmermann","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.012_bib69","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1182\/blood.2021014612","article-title":"Avapritinib for advanced systemic mastocytosis","volume":"140","author":"Gotlib","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.05.012_bib70","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/all.15585","article-title":"Anti-KIT antibody, barzolvolimab, reduces skin mast cells\u00a0and disease activity in chronic inducible urticaria","volume":"78","author":"Terhorst-Molawi","year":"2023","journal-title":"Allergy"}],"updated-by":[{"DOI":"10.1016\/j.jaip.2023.07.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000}}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823005482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823005482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T16:38:05Z","timestamp":1736872685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823005482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2213219823005482"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.05.012","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jaip.2023.07.011","asserted-by":"object"}]},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease Spectrum of Anaphylaxis Disorders","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}